Results 301 to 310 of about 132,013 (384)

Heart Rate Variability as a Marker of Disease Severity in Pulmonary Arterial Hypertension: A Prospective Cohort Study

open access: yesPulmonary Circulation, Volume 15, Issue 2, April 2025.
ABSTRACT Pulmonary arterial hypertension (PAH) is a disease that can eventually progress to right ventricular failure. Heart rate variability (HRV), including standard deviation of R‐to‐R intervals (SDNN), has been associated with increased mortality across different populations.
Arun Jose   +4 more
wiley   +1 more source

Effect of primary-care spirometry on the diagnosis and management of COPD [PDF]

open access: bronze, 2006
Paul Walker   +4 more
openalex   +1 more source

Examining discordance in spirometry reference equations: A retrospective study. [PDF]

open access: yesPhysiol Rep
Zavorsky GS   +6 more
europepmc   +1 more source

Lymphoid Interstitial Pneumonia Without Known Cause: Diagnostic Work Up and Differential Considerations

open access: yesRespirology Case Reports, Volume 13, Issue 4, April 2025.
We present a case of diffuse cystic lung disease without any known underlying systemic disorder, biopsy confirmed as lymphoid interstitial pneumonia (LIP). This case highlights the benefit of histological confirmation where there is diagnostic uncertainty and the clinical situation permits, particularly in the setting of symptomatic deterioration ...
Han Xin Lau   +3 more
wiley   +1 more source

Risk of All-Cause Mortality in Mild Chronic Obstructive Pulmonary Disease: Evidence From the NHANES III and 2007-2012. [PDF]

open access: yesInt J Chron Obstruct Pulmon Dis
Zou W   +12 more
europepmc   +1 more source

The role of small or single-institution prospective studies in thoracic research [PDF]

open access: yes, 2019
Frye, C. Corbin   +6 more
core   +1 more source

Omalizumab reduces anaphylactic reactions and allows food introduction in food‐allergic in children with severe asthma: An observational study

open access: yesAllergy, Volume 80, Issue 4, Page 1074-1085, April 2025.
In Europe, Omalizumab is indicated for the treatment of moderate to severe asthma, but not for IgE‐mediated food allergy. We assessed the impact of Omalizumab on efficacy, safety, and the quality of life (FA‐QoL) in patients with moderate to severe asthma and who have a history of anaphylaxis to peanut, tree nuts, fish, egg, milk, and/or wheat.
Stefania Arasi   +14 more
wiley   +1 more source

Spirometry in CF patients

open access: yesJournal of Cystic Fibrosis, 2008
D. Russell   +4 more
openaire   +2 more sources

Point‐of‐Care Blood Eosinophils to Predict Preschool Wheeze Attacks

open access: yesAllergy, Volume 80, Issue 4, Page 1038-1046, April 2025.
Absolute and % BEC at baseline are higher in children who had > 1 wheeze attack requiring unscheduled healthcare attendance in follow‐up period. Decision tree model shows children with BEC ≥ 4% and TRACK score < 75 are more likely to have a future attack.
Kushalinii Hillson   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy